Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 42.93B | 43.75B | 42.29B | 41.92B | 43.46B | 49.08B |
Gross Profit | 3.33B | 3.66B | 3.92B | 4.30B | 3.42B | 2.80B |
EBITDA | 943.71M | 1.42B | 932.37M | 1.68B | 1.18B | 835.33M |
Net Income | 336.15M | 642.78M | 292.55M | 897.50M | 748.17M | 497.46M |
Balance Sheet | ||||||
Total Assets | 19.21B | 16.64B | 18.58B | 16.86B | 20.89B | 20.40B |
Cash, Cash Equivalents and Short-Term Investments | 6.04B | 6.59B | 5.97B | 4.19B | 6.33B | 6.24B |
Total Debt | 8.49B | 5.97B | 8.09B | 6.35B | 11.44B | 11.10B |
Total Liabilities | 12.11B | 9.23B | 11.50B | 9.91B | 14.50B | 14.63B |
Stockholders Equity | 7.10B | 7.40B | 7.08B | 6.93B | 6.38B | 5.77B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 3.05B | 1.02B | 4.56B | 746.32M | -604.69M |
Operating Cash Flow | 0.00 | 3.07B | 1.03B | 4.58B | 747.66M | -602.42M |
Investing Cash Flow | 0.00 | -39.26M | -70.61M | -15.93M | 7.76M | 1.85M |
Financing Cash Flow | 0.00 | -2.46B | 473.04M | -6.77B | -866.74M | 862.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥5.82B | 8.59 | 4.37% | 3.45% | 130.05% | ||
77 Outperform | ¥28.55B | 8.26 | 1.77% | 36.47% | 454.90% | ||
75 Outperform | ¥29.34B | 8.89 | 3.41% | 3.61% | -14.91% | ||
69 Neutral | ¥229.66B | 14.25 | 7.50% | 2.73% | 9.14% | 8.34% | |
58 Neutral | ¥14.93B | ― | 4.10% | -6.97% | 45.07% | ||
55 Neutral | ¥2.64B | 160.51 | ― | 50.79% | -59.24% | ||
43 Neutral | ¥3.84B | 31.45 | 1.73% | -8.12% | -102.86% |